Author

S. J. Gonzales

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

E. M. Bunnik· 2 shared R. Garza· 2 shared S. Bol· 2 shared A. E. Braddom· 1 shared A. M. Cantwell· 1 shared B. M. Greenhouse· 1 shared G. Batugedara· 1 shared G. C. Ippolito· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. M. Bunnik

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A comparative analysis of memory B cell and antibody responses against Plasmodium falciparum merozoite surface protein 1 in children and adults from Uganda

S. J. Gonzales, K. N. Clarke, G. Batugedara, A. E. Braddom, R. Garza, R. A. Reyes, I. Ssewanyana, K. C. Garrison, G. C. Ippolito, B. M. Greenhouse, S. Bol, E. M. Bunnik

The paper compares memory B cell and antibody responses against Plasmodium falciparum MSP1 in Ugandan children and adults, showing shifts from IgM to IgG and diversification with exposure.

bioRxiv · Nov 4, 2021Immunology

SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease

R. Reyes, K. Clarke, S. J. Gonzales, A. M. Cantwell, R. Garza, G. Catano, R. E. Tragus, T. F. Patterson, S. Bol, E. M. Bunnik

This study compares memory B cell responses in non-severe and severe COVID-19 patients, finding that non-severe cases show stronger durable immunity markers.

bioRxiv · Sep 24, 2021Immunology